drugset / Trial / NCT00971152

Effect of a Higher Than Maximum 450IU Gonadotropin Dose in an In-vitro Fertilization Cycle

NCT00971152 ↗

Phase 3 Completed 366 enrolled Clinique Ovo Ferring Pharmaceuticals · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

This goal of this study is to evaluate the outcomes from in vitro fertilization cycles where a 450 IU daily dose of gonadotropins is administered compared to those where a 600 IU daily dose is administered for women who are at risk of a poor ovarian response in order to determine if one dose or the other results in improved cycle outcomes.

Timeline

Start
2009-09
Primary completion
2013-10
Completion
2014-02

Outcome

Missed primary endpoint

paper Gonadotropin of 600 IU/d does not improve outcome of IVF cycles compared with 450 IU/d in women at risk of poor ovarian response. PMID 26361207 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Bravelle Unknown 225 iu —
Subject Bravelle Unknown 300 iu —
Subject Menopur Protein / enzyme biologic 225 iu —
Subject Menopur Protein / enzyme biologic 300 iu —

Indications